(Q24553346)

English

Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization

scientific article

In more languages

default for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization (English)

0 references

0 references

4

Michael J Cima

0 references

author name string

Sherry L Morissette

series ordinal

1

0 references

Stephen Soukasene

series ordinal

2

0 references

Douglas Levinson

series ordinal

3

0 references

Orn Almarsson

series ordinal

5

0 references

language of work or name

English

0 references

publication date

4 March 2003

0 references

published in

Proceedings of the National Academy of Sciences of the United States of America

0 references

volume

100

0 references

issue

5

0 references

page(s)

2180-4

0 references

cites work

ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151315

retrieved

24 March 2017

Ritonavir: an extraordinary example of conformational polymorphism

2 references

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151315

24 March 2017

https://api.crossref.org/works/10.1073%2FPNAS.0437744100

retrieved

21 January 2018

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=151315

retrieved

7 April 2017

Iterative high-throughput polymorphism studies on acetaminophen and an experimentally derived structure for form III.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1073%2FPNAS.0437744100

retrieved

21 January 2018

Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1073%2FPNAS.0437744100

retrieved

21 January 2018

Disappearing Polymorphs

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1073%2FPNAS.0437744100

retrieved

21 January 2018

Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1073%2FPNAS.0437744100

retrieved

21 January 2018

Solid-state behavior of cromolyn sodium hydrates

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1073%2FPNAS.0437744100

retrieved

21 January 2018

Identifiers

DOI

10.1073/PNAS.0437744100

0 references

0 references

0 references

PubMed publication ID

12604798

0 references

ResearchGate publication ID

10884054

0 references

(Q24553346)

Elucidation of crystal form diversity of the HIV protease inhibitor ritonavir by high-throughput crystallization

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)